Full-Time

Medical Science Liaison

Msl, Prenatal

Confirmed live in the last 24 hours

BillionToOne

BillionToOne

201-500 employees

Molecular diagnostics for prenatal and oncology testing

Biotechnology
Healthcare

Compensation Overview

$132.6k - $153kAnnually

+ Equity Options + Bonus Program

Mid, Senior

Remote in USA

Candidate must reside in the Northeast Region, Texas, or Florida.

Category
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary

You match the following BillionToOne's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Master’s degree in Genetic Counseling
  • Board certified ABGC or ABMG
  • 3-5 years of prenatal clinical and/or industry experience in related field required
  • Expertise in discussing scientific content and context to multiple audiences
  • Excellent communication, presentation and interpersonal skills
  • Ability to travel (up to 70%) – percentage varies with geography
Responsibilities
  • Serve as a key liaison to health care providers (HCPs)
  • Serve as a key member of the BillionToOne Medical Affairs team
  • Develop relationships by engaging in scientific exchange with medical and scientific partners
  • Support commercial team by providing impactful information that enhances the value and proper use of BillionToOne products
  • Respond to HCP customer inquiries to provide focused and balanced clinical and scientific information that supports the appropriate use of BillionToOne’s prenatal products
  • Provide education regarding the clinical differentiation of BillionToOne's products and services
  • Contribute to development of provider and patient educational products
  • Adhere to internal standard processes and comply with regulatory and compliance requirements

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne's business model centers on providing these diagnostic services directly to healthcare providers, generating revenue through the sale of testing services that inform treatment decisions. The goal of BillionToOne is to enhance the accuracy, efficiency, and accessibility of molecular testing, driven by a commitment to growth, equality, and teamwork in making a positive impact on healthcare.

Company Stage

Series D

Total Funding

$380.2M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

1%

1 year growth

0%

2 year growth

2%
Simplify Jobs

Simplify's Take

What believers are saying

  • BillionToOne achieved over 100% revenue growth, reaching $153 million in 2024.
  • The company secured a billion-dollar valuation with a $130 million funding round.
  • Expansion in Austin, Texas, will create 1,000 jobs and increase production capacity.

What critics are saying

  • Emerging startups in molecular diagnostics could erode BillionToOne's market share.
  • Rapid technological advancements require continuous innovation to maintain competitiveness.
  • Economic instability in target markets may affect product affordability and adoption.

What makes BillionToOne unique

  • BillionToOne's QCT technology detects DNA variations at single base-pair resolution.
  • Their non-invasive prenatal tests replace risky procedures like amniocentesis.
  • Northstar products offer precise therapy selection and monitoring for oncology patients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging